Mannose-binding lectin and mortality in patients with type 2 diabetes mellitus - secondary publication;Mannanbindende lektin og mortalitet hos patienter med type 2-diabetes - sekundærpublikation

Ugeskrift for Laeger

Volumn 171, Issue 6, 2009, Pages 426-429

  Hansen, Troels Krarup ^a   Mari Anne Gall, ^b   Lise Tarnow, ^c   Steffen Thiel, ^d   Hans Henrik Parving, ^e   Allan Flyvbjerg, ^f  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Medicinsk Afdeling M og Medicinsk Forskningslaboratorium   (Denmark)

^c STENO DIABETES CENTER   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e Institut for Medicinsk Mikrobiologi og Immunologi   (Denmark)

^f University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; MANNOSE BINDING LECTIN;

ALBUMINURIA; ARTICLE; BLOOD; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR;

ALBUMINURIA; C-REACTIVE PROTEIN; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 59849115211     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Gæde P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93.
2. Walport MJ. Complement. First of two parts. N Engl J Med 2001;344:1058-66.
3. Hansen TK, Tarnow L, Thiel S et al. Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 2004;53:1570-6.
4. Hovind P, Hansen TK, Tarnow L et al. Mannose-binding lectin as a predictor of microalbuminuria in type 1-diabetes: an inception cohort study. Diabetes 2005;54:1523-7.
5. Malhotra R, Wormald MR, Rudd PM et al. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995;1:237-43.
6. Collard CD, Vakeva A, Morrissey MA et al. Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol 2000;156:1549-56.
7. Jordan JE, Montalto MC, Stahl GL. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 2001;104:1413-8.
8. Walsh MC, Bourcier T, Takahashi K et al. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 2005;175:541-6.
9. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21.
10. Qin X, Goldfine A, Krumrei N et al. Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes. Diabetes 2004;53:2653-61.